Amantadine Hydrochloride, closely related to Amantadine (CAS 768-94-5), shares many of its therapeutic applications and functions as a key pharmaceutical intermediate. Its well-established role in medicine spans the treatment of viral infections, particularly Influenza A, and the management of Parkinson's disease symptoms. In the context of influenza, Amantadine acts by inhibiting the M2 proton channel of the virus, disrupting viral uncoating and replication. This antiviral property makes it a historically significant compound in public health strategies. Beyond its antiviral capabilities, Amantadine Hydrochloride's utility in treating Parkinson's disease is attributed to its influence on dopaminergic pathways in the brain. It is believed to enhance the release of dopamine, a neurotransmitter crucial for motor control, thereby alleviating symptoms such as rigidity, tremor, and bradykinesia. This makes it a valuable component in the formulation of antiparkinsonian drugs. As a pharmaceutical intermediate, the availability of high-quality Amantadine Hydrochloride is critical for drug manufacturers. Sourcing this compound from reliable providers, such as leading chemical suppliers in China, ensures that drug development projects can proceed with confidence. Companies often look for suppliers that can provide Amantadine Hydrochloride with specific purity levels, such as 99% minimum assay, and appropriate certifications. The consistent quality and competitive pricing offered by Chinese manufacturers, including TNJ Chemical, make them an attractive option for global pharmaceutical companies looking to buy Amantadine Hydrochloride. The compound's chemical properties also lend themselves to other research applications, including its use in studying neurodegenerative diseases and as a tool in pharmacological research. The consistent supply of this intermediate is vital for ensuring the uninterrupted production of essential medications and for driving innovation in pharmaceutical development.